drugset / Trial / NCT01701362

Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain

NCT01701362

Phase 3 Completed 542 enrolled Viatris Inc.
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to investigate if pregabalin is effective in treating neuropathic (nerve) pain resulting from peripheral nerve trauma due to a traumatic or surgical event such as, for example, motor vehicle accident, fall, sports injury, knee or hip replacement, hernia repair, thoracotomy, mastectomy, focal/localized burns or crush injury.

Timeline

Start
2012-10
Primary completion
2015-08
Completion
2015-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pregabalin Small molecule 150 mg
Comparator Pregabalin Small molecule 600 mg

Indications